RHEED characterisation of the near surface microstructure of Ti-O based biocompatible coatings

Mechanically polished, annealed, nitric acid treated and aged in boiling water after nitriding, commercially pure Ti substrates have been characterised using reflection high-energy electron diffraction (RHEED) and secondary electron imaging, in terms of their naturally formed or ‘accelerated’ oxide layers. Annealing induced crystallisation and transformation of anatase to the rutile phase and led to increased roughness, with localised fracture and balling up of the surface oxide layer as the time and temperature of annealing were increased. Nitric acid modification produced no influence on the anatase to rutile transformation, whilst further aging in boiling water induced an acceleration of this transformation. RHEED data acquired at differing accelerating voltages have indicated a Ti-O phase gradation within annealed sol-gel derived V modified TiO2 layers deposited by spin coating onto Ti substrates

Laser sintering of nano-hydroxyapatite coated polyamide 12 powders

As part of a larger study on the laser sintering (LS) of nano-composite structures for biomedical applications, a wet mixing method was used to coat Polyamide 12 (PA12) particles with nano-hydroxyapatite (nHA). The addition of nHA significantly affected powder processability due to laser absorption and heat transfer effects which led to part warping. This phenomenon has not been reported in other studies investigating LS of polymer/HA and nHA powders. Nano-composites containing 0.5–1.5 wt% nHA were successfully produced and tensile testing showed that 0.5 wt% nHA provided the greatest reinforcement with a 20% and 15% increase in modulus and strength respectively. However, the elongation at break had significantly declined which was likely due to the formation of nHA aggregates at the sintering borders following the processing of the coated powders despite being initially well dispersed on the particle surface

Spheroidisation of metal powder by pulsed electron beam irradiation

A new powder spheroidisation process has been demonstrated using a large-area, pulsed electron beam technique. This was used to dramatically improve the surface morphology of Stellite 6 metal powder. Powder surface asperities up to 20 μm size can be eliminated by melting and incorporation into the near-surface of the particle. Surface finish is significantly improved. Agitation and rotation of particles due to a beam-induced stress wave enables the irradiation of multiples sides of particles, resulting in uniformly smoothed particles after sufficient pulses. Elemental analysis revealed no measurable contamination as a result of the process. Transmission electron microscopy showed a dense layer is produced within a zone up to 3 μm beneath the surface, with a substantially reduced grain size from ca. 2 μm diameter in the bulk to ca. 40 nm. Elemental homogenisation also was accompanied by grain refinement. The irradiated Stellite 6 showed a reduced basic flowability energy (583 mJ compared to 627 mJ for the untreated), explained by reduced particle-particle cohesion and interlocking, and an increased conditioned bulk density of 4.57 g/ml compared to 4.33 g/ml due to satellite/asperity reduction

Microstructural characterisation of biocompatible sol-gel derived vanadium doped TiO2 on Ti substrates

Sol-gel derived pure titania is compared with vanadium and / or aluminium modified titania deposited by spin coating on pure titanium substrates annealed at 300C and 650C. Reflection high-energy electron diffraction indicated the presence of anatase from the surface layers of samples annealed at 300C with a transition to rutile with increasing annealing temperature and addition of vanadium. Cross-sectional transmission electron microscopy indicated a gradation of Ti-O phases through the layer with the dominant presence of rutile. Aluminium was found to inhibit grain growth while vanadium promoted crystallisation

The cessation in pregnancy incentives trial (CPIT): study protocol for a randomized controlled trial

Background: Seventy percent of women in Scotland have at least one baby, making pregnancy an opportunity to help most young women quit smoking before their own health is irreparably compromised. By quitting during pregnancy their infants will be protected from miscarriage and still birth as well as low birth weight, asthma, attention deficit disorder and adult cardiovascular disease. In the UK, the NICE guidelines: 'How to stop smoking in pregnancy and following childbirth' (June 2010) highlighted that little evidence exists in the literature to confirm the efficacy of financial incentives to help pregnant smokers to quit. Its first research recommendation was to determine: Within a UK context, are incentives an acceptable, effective and cost-effective way to help pregnant women who smoke to quit? <p/>Design and Methods: This study is a phase II exploratory individually randomised controlled trial comparing standard care for pregnant smokers with standard care plus the additional offer of financial voucher incentives to engage with specialist cessation services and/or to quit smoking during pregnancy. Participants (n=600) will be pregnant smokers identified at maternity booking who when contacted by specialist cessation services agree to having their details passed to the NHS Smokefree Pregnancy Study Helpline to discuss the trial. The NHS Smokefree Pregnancy Study Helpline will be responsible for telephone consent and follow-up in late pregnancy. The primary outcome will be self reported smoking in late pregnancy verified by cotinine measurement. An economic evaluation will refine cost data collection and assess potential cost-effectiveness while qualitative research interviews with clients and health professionals will assess the level of acceptance of this form of incentive payment. Research questions What is the likely therapeutic efficacy? Are incentives potentially cost-effective? Is individual randomisation an efficient trial design without introducing outcome bias? Can incentives be introduced in a way that is feasible and acceptable? <p/>Discussion: This phase II trial will establish a workable design to reduce the risks associated with a future definitive phase III multicentre randomised controlled trial and establish a framework to assess the costs and benefits of financial incentives to help pregnant smokers to quit

Black Hole Production from High Energy Scattering in AdS/CFT

In this article we show how to set up initial states in ${\cal N} =4$ SYM theory that correspond to high energy graviton collisions, leading to black hole formation in $AdS_5\times S^5$. For this purpose, we study states in the gauge theory that are dual to graviton wavepackets localized at the center of $AdS_5$, and carrying large angular momentum along the $S^5$. These states are created by exciting only the s-wave mode of one of the complex adjoint scalars of SYM. For a single graviton, the state is 1/2 BPS and one can show that it is dual to a linearized 1/2 BPS geometry in the bulk. Exploiting this dictionary, we show how to localize the particle's wavefunciton so that the dual linearized metric has the form of a Aichelburg-Sexl shock wave. One can then put two such shock waves into a head-on collision, which is known to produce a trapped surface. Finally, we discuss the prospect of studying graviton scattering directly at strong coupling in the gauge theory using a reduced model of matrix quantum mechanics.Comment: 11 pages, revtex format, no figure

Transient serum exposure regimes to support dual differentiation of human mesenchymal stem cells

Human mesenchymal stem cells (MSCs), which can generate both osteoblasts and chondrocytes, represent an ideal resource for orthopaedic repair using tissue-engineering approaches. One major difficulty for the development of osteochondral constructs using undifferentiated MSCs is that serum is typically used in culture protocols to promote differentiation of the osteogenic component, whereas existing chondrogenic differentiation protocols rely on the use of serum-free conditions. In order to define conditions which could be compatible with both chondrogenic and osteogenic differentiation in a single bioreactor, we have analysed the efficiency of new biphasic differentiation regimes based on transient serum exposure followed by serum-free treatment. MSC differentiation was assessed either in serum-free medium or with a range of transient exposure to serum, and compared to continuous serum-containing treatment. Although osteogenic differentation was not supported in the complete absence of serum, marker expression and extensive mineralization analyses established that 5 days of transient exposure triggered a level of differentiation comparable to that observed when serum was present throughout. This initial phase of serum exposure was further shown to support the successful chondrogenic differentiation of MSCs, comparable to controls maintained in serum-free conditions throughout. This study indicates that a culture based on temporal serum exposure followed by serum-free treatment is compatible with both osteogenic and chondrogenic differentiation of MSCs. These results will allow the development of novel strategies for osteochondral tissue engineering approaches using MSCs for regenerative medicine

Independent and complementary bio-functional effects of CuO and Ga2O3 incorporated as therapeutic agents in silica- and phosphate-based bioactive glasses

The incorporation of therapeutic-capable ions into bioactive glasses (BGs), either based on silica (SBGs) or phosphate (PBGs), is currently envisaged as a proficient path for facilitating bone regeneration. In conjunction with this view, the single and complementary structural and bio-functional roles of CuO and Ga2O3 (in the 2–5 mol% range) were assessed, by deriving a series of SBG and PBG formulations starting from the parent glass systems, FastOs®BG – 38.5SiO2—36.1CaO—5.6P2O5—19.2MgO—0.6CaF2, and 50.0P2O5—35.0CaO—10.0Na2O—5.0 Fe2O3 (mol%), respectively, using the process of melt-quenching. The inter-linked physico-chemistry – biological response of BGs was assessed in search of bio-functional triggers. Further light was shed on the structural role – as network former or modifier – of Cu and Ga, immersed in SBG and PBG matrices. The preliminary biological performance was surveyed in vitro by quantification of Cu and Ga ion release under homeostatic conditions, cytocompatibility assays (in fibroblast cell cultures) and antibacterial tests (against Staphylococcus aureus). The similar (Cu) and dissimilar (Ga) structural roles in the SBG and PBG vitreous networks governed their release. Namely, Cu ions were leached in similar concentrations (ranging from 10–35 ppm and 50–110 ppm at BG doses of 5 and 50 mg/mL, respectively) for both type of BGs, while the release of Ga ions was 1–2 orders of magnitude lower in the case of SBGs (i.e., 0.2–6 ppm) compared to PBGs (i.e., 9–135 ppm). This was attributed to the network modifier role of Cu in both types of BGs, and conversely, to the network former (SBGs) and network modifier (PBGs) roles of Ga. All glasses were cytocompatible at a dose of 5 mg/mL, while at the same concentration the antimicrobial efficiency was found to be accentuated by the coupled release of Cu and Ga ions from SBG. By collective assessment, the most prominent candidate material for the further development of implant coatings and bone graft substitutes was delineated as the 38.5SiO2—34.1CaO—5.6P2O5—16.2MgO—0.6CaF2—2.0CuO—3.0Ga2O3 (mol%) SBG system, which yielded moderate Cu and Ga ion release, excellent cytocompatibility and marked antibacterial efficacy.publishe